We focus our SMART THINKING and unmatched legal knowledge to represent businesses WORLDWIDE in nearly every industry.

We’ve helped shape the playing field

To a degree perhaps unequaled in almost any other industry, patents represent a major part of the foundation for the biotechnology and pharmaceutical industries’ business success. Our firm's preeminent Life Sciences team has been helping to shape this playing field since its embryonic stage. Kenyon & Kenyon LLP has dozens of attorneys who, with their technical training in chemistry, biology, and medicine coupled with their command of the legal landscape, successfully solve today’s pressing questions affecting these growing industries.

From gene chips to drug metabolism, we’ve got the strategic therapy

Kenyon's biotech and pharma experience runs the gamut of technologies. We’ve handled matters in such diverse areas as:

  • Active pharmaceutical ingredients
  • Antisense technology
  • Biochemistry
  • Bio-informatics
  • Cell biology
  • Drug delivery systems
  • Gene therapy
  • Genomics
  • Immunology
  • Microarrays
  • Proteomics
  • Drug metabolism
  • Drug synthesis
  • Tissue engineering
  • Vaccines

Real success speaks for itself

Our clients have a record of success in court that speaks volumes about our abilities in the biotech and pharma fields.

Kenyon's deep experience in the biotech and pharma industries permits us to tackle just about any issue with the right team. Our teams regularly assist our clients in court. Additionally, a number of our partners have argued and won for our clients at the Court of Appeals for the Federal Circuit. Indeed, our attorneys know first hand just what it takes to succeed. Kenyon assigns the right people to the project from the beginning, whether it is a cornerstone patent application for a biotech startup, securing and protecting the name of a new product, due diligence and contract work for that key deal or investment, patent clearance for the next big development candidate, or a trial involving a patent challenge to a blockbuster drug.